The company expects revenues to between $33 million and $35 million, up from $12.1 million in the first quarter of 2014.
Historically, the company has produced approximately 14 percent of its annual revenue in the first quarter of the year.
More articles on transactions and valuation issues:
NAPA announces partnership with Virginia Eye Institute
Sentara Northern Virginia Medical Center to build $40M ASC
AmSurg stock rated at ‘buy’
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.